| Financial Year |
March 31 2023 |
| Monetary Funds |
98,065,054.30 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
9,788,152.77 |
| Accounts Receivable |
232,099,024.03 |
| Advances to Suppliers |
23,442,874.81 |
| Other Receivables |
17,927,421.89 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
682,989,165.68 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
23,924,956.27 |
| Total Current Assets |
1,090,082,567.75 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
44,039,256.50 |
| Investment Properties |
-- |
| Fixed Assetes |
761,411,203.61 |
| Under-construction Projects |
43,777,810.60 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
88,848,563.38 |
| R&D expenses |
-- |
| Goodwill |
34,975,835.14 |
| Long-Term Deferred and Prepaid Expenses |
724,883.87 |
| Deferred Income Tax Assets |
21,853,511.33 |
| Other Non-Current Assets |
171,610,020.59 |
| Sub-Total of Non-Current Assets |
1,178,188,525.26 |
| Total Assets |
2,268,271,093.01 |
| Short-Term Loans |
306,207,778.43 |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,900,000.00 |
| Accounts Payable |
225,072,192.82 |
| Accounts Received In Advance |
28,200,947.13 |
| Employee Compensation Payable |
14,240,481.08 |
| Taxes Payable |
8,952,870.49 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
23,535,201.53 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
29,594,279.95 |
| Other Current Liabilities |
54,115,959.49 |
| Sub-Total of Current Liabilities |
1,096,236,071.09 |
| Long-term Loans |
20,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
2,002,866.00 |
| Other Non-Current Liabilities |
11,918,044.61 |
| Sub-Total of Non-Current Liabilities |
67,355,604.08 |
| Total Liabilities |
1,163,591,675.17 |
| Paid-In Capital(Or Share Stock) |
385,999,052.00 |
| Capital Surplus |
800,114,422.49 |
| Surplus Reserve |
92,770,510.27 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-216,878,825.92 |
| Minority Stockholder's Interest |
43,068,614.17 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,061,610,803.67 |
| Owner's Equity（Stockholder's Equity） |
1,104,679,417.84 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,268,271,093.01 |
